Direct Oral Anticoagulants and Dementia Risk in Nonvalvular Atrial Fibrillation: Evidence to Guide Clinical Selection
Large real-world study found no meaningful dementia risk differences between apixaban, edoxaban, and rivaroxaban, supporting DOAC selection based on safety, adherence, renal function, and patient needs.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.